Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Xenazine current manufacturer 2025?Antiox mebendazole price?Patent expiration eu dabrafenib?What are the most memorable drug brands in oral factor b inhibitors? in united states
See the DrugPatentWatch profile for ranitidine
Ranitidine (H2‑receptor antagonist) – Commonly known as Zantac Ranitidine is used to reduce stomach acid production. It works by blocking histamine‑2 receptors on gastric parietal cells, thereby decreasing acid secretion. Typical therapeutic uses include: | Condition | Typical Ranitidine Use | |-----------|------------------------| | Gastro‑oesophageal reflux disease (GERD) | Short‑term (usually 4–8 weeks) to relieve heartburn, regurgitation, and esophagitis. | | Peptic ulcer disease (gastric or duodenal) | Short‑term or maintenance therapy when combined with an ulcer‑healing regimen (e.g., proton pump inhibitor or antibiotic for H. pylori). | | Zollinger–Ellison syndrome (gastric acid hypersecretion due to gastrinoma) | Acute control of severe acid hypersecretion; often combined with a proton‑pump inhibitor. | | Acid‑related dyspepsia (indigestion, bloating, epigastric discomfort) | Short‑term symptom relief. | | Pre‑operative prophylaxis for patients at risk of stress‑induced gastric ulcers. | A single dose or short course before surgery. | | Prevention of NSAID‑induced gastric ulcers in high‑risk patients. | Often used in combination with a proton‑pump inhibitor for stronger acid suppression. |
Other Questions About Ranitidine :